Michael H. Cullen

发表

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.

S. Fosså, A. Horwich, J. Aparicio, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

M. Williams, S. Fosså, D. Dearnaley, 2005, British Journal of Cancer.